Babesia gibsoni (B. gibsoni) is the predominant tick-borne protozoan blood parasite that causes hemolytic anemia, thrombocytopenia, lethargy, and splenomegaly. It has recently been recognized as an important pathogen that affects dogs in the Middle East, Africa, Asia, Europe, and the Americas. The suspected specific vectors of Babesia gibsoni infection are: Rhipicephalus sanguineus commonly called the brown dog tick, and Haemaphysalis ticks, and it can easily be transmitted by bites especially for dogs who 
come from fighting backgrounds, from dams to puppies, and also through blood transfusion.

Dogs with the parasite or infected by the Babesia gibsoni can even lead to death if left untreated.

The most sensitive test for B. gibsoni is “the PCR test” which is a process that delays results and adds costs.

In that regard, Bioguard with the aim to provide the most convenient, accurate, and reliable solution for the animal care industry has developed the Babesia gibsoni test to facilitate mass screening of high‐risk dogs and monitoring of response to treatment for infected dogs.

The Objective of that study comparing the Bioguard VETlabs test directly to PCR is to give you a better comprehension of the performance of the Bioguard VETlabs B. gibsoni test.

The study showed that Bioguard laboratories have taken 54 infected positives specimen and 72 non-infected-negatives specimens.

The result of the study is as follow

Bioguard compared with PCR

Sensitivity: 96.29%

Specificity: 91.66%

According to the study, the Bioguard VETlabs Babesia gibsoni test is a convenient, accurate, and reliable test with 96.29% Sensitivity and 91.66% Specificity.

Bioguard “Science for Animal Care” dedicated to supporting veterinarians throughout the world with the most convenient and highest quality service in the veterinary rapid diagnostic.



The Bioguard Corporation’s participation for the 12^th East and West Small Animal Clinical Veterinary Conference was rescheduled on November 24- 26, 2020 due to the COVID19 pandemic.

Bioguard has been participating in the event every year and showcases the high-quality veterinary products that we developed and manufactured. However, the WESAVC has announced the postponement of the conference for the year 2020, in relation to the current global status amidst the COVID19 pandemic.

The WESAVC is yearly held in China as one of the biggest events for small animal veterinary, participated by increasing number of exhibitors all over the world. Professional talks are being given by clinical experts and specialists in small animal veterinary during the conference.

Industries related to small animals: pet medical; pet foods; and pet supplies are expected to gather and bridge the gap in communicating and providing innovative technology for the small animal veterinary. Given the circumstances, everyone is reminded to stay safe and healthy.



Read more

Ceva Animal Health, manufacturer of the veterinary behavioral products Adaptil and Feliway, has acquired ThunderWorks, which is best known for its ThunderShirt range of calming pet coats.



Ceva says the acquisition is a natural fit for Ceva’s extensive behavioral range and will bolster its Adaptil portfolio to offer a wider variety of anxiety solutions for dogs.  The company will be responsible for the UK sales and marketing of the ThunderShirt and says it will use its knowledge and expertise in the pet retail sector to further enhance the reach of its extensive range of market-leading behavioral products.



Read more

Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) are both retroviruses that vitally affect domestic cat’s populations. Although caused by distinct viruses, these diseases have similarities: both are contagious and incurable; both are more likely to be acquired by a cat that is allowed outside.

Unlike some forms of viruses that infect cells and then kill them, FeLV and FIV actually alter 

the genetic material of the infected cell and turn cells into little virus factories. This process takes time, so in both cases, cats may be infected for many years before becoming clinically ill.

FeLV and FIV in cats are serious and unfortunately incurable diseases, the best way to prevent the spread of these diseases is to have your cat tested regularly.The Bioguard VETlabs Feline leukemia Virus (FeLV) Ag/ Feline immunodeficiency Virus (FIV) Ab Combo Test is a sandwich lateral flow immunochromatographic assay, developed by Bioguard Corporation for enabling the simplicity of rapidly testing or detecting the feline leukemia virus antigen and feline immunodeficiency Virus antibody in cat’s blood.



Read more

About Bioguard Corporation

Bioguard is a Company focuses on animal

disease diagnostic services and products.
Our animal health diagnostic center is

the first and only ISO/ IEC 17025 accredited animal disease testing laboratory

in Taiwan and China.

Copyright © Bioguard Corp., All rights reserved.

Our mailing address is: [email protected]